Halozyme Therapeutics, Inc. (HALO)
62.13
+0.50
(+0.81%)
USD |
NASDAQ |
Mar 30, 16:00
62.04
-0.09
(-0.14%)
After-Hours: 19:33
Halozyme Therapeutics Market Cap : 7.332B for March 30, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 584.02B |
| Skye Bioscience, Inc. | 19.59M |
| Eli Lilly & Co. | 792.10B |
| Stryker Corp. | 124.78B |
| Glaukos Corp. | 6.101B |
Market Cap Related Metrics
| PE Ratio | 24.93 |
| PS Ratio | 5.459 |
| Price to Book Value | 150.21 |
| Price to Free Cash Flow | 11.83 |
| Price | 62.13 |
| Earnings Yield | 4.01% |
| Operating PE Ratio | 9.339 |
| Normalized PE Ratio | 13.53 |